Fig. 1From: Hospital-based headache care during the Covid-19 pandemic in Denmark and NorwayBotulinum toxin A (BTX) treatment in Denmark (white) and Norway (black) during the lockdown. Respondents replied to the question “Did your Department continue botulinum toxin treatment for chronic migraine during the pandemic?”Back to article page